阿尔法-1抗素缺乏变体对聚合物阻断疗法的敏感性
Riccardo Ronzoni1,2, Ibrahim Aldobiyan1,2,3, Elena Miranda4
1UCL Respiratory, Division of Medicine, and.
JCI insight
|July 8, 2025
概括
阿尔法-1抗素 (AAT) 的Z变体通过形成聚合物引起肝病. 一些AAT突变会形成对药物GSK716耐药的聚合物,这表明这些个体的治疗益处有限.
科学领域:
- 生物化学 生化学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 阿尔法-1抗素 (AAT) 缺乏可能导致肝脏疾病由于聚合物形成.
- Z变体 (Glu342Lys) 是AAT相关肝病的常见原因.
- GSK716 (716) 是一种抑制AAT聚合的小分子.
研究的目的:
- 描述23种AAT突变的聚合物形成,GSK716的抑制,以及2C1表位的暴露.
- 为了识别对GSK716治疗有抗性的AAT突变.
- 了解GSK716抗性的结构基础及其对治疗策略的影响.
主要方法:
- 细胞模型来评估AAT突变者的行为.
- 用GSK716进行治疗,以评估抑制聚合物形成.
- 单克隆抗体 (mAb) 2C1和8A7染色以检测聚合物和表位.
主要成果:
- 大多数AAT变体形成了细胞内聚合物.
- 11种变种形成了对GSK716.6具有抗药性的聚合物.
- 局部化到AAT的不同区域的GSK716耐药聚合物,mAb 2C1不太能识别,但mAb 8A7.7能识别.
结论:
- 某些AAT突变通过将聚合物稳定在一个独特的结构状态中,从而赋予了对GSK716的抗性.
- 具有抗GSK716的AAT突变的个体可能不会从当前或类似的治疗方法中受益.
- 8A7 mAb为AAT聚合物提供了更广泛的检测方法.
更多相关视频
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.9K
07:00A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
10.1K
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
Translesion DNA Polymerases
10.1K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.1K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
250
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
250
